STOCK TITAN

Aligos Therapeutics: Alyeska reports 5.64% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Aligos Therapeutics, Inc. (ALGS) is the subject of an amended beneficial-ownership report in which Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh report beneficial ownership of 352,472 shares, or 5.64% of the class, as of September 30, 2026. The shares are Common Stock issuable upon exercise of warrants, with shared voting and dispositive power reported.

The position is held by Alyeska Master Fund, L.P.; Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control. Anand Parekh, identified as the investment manager’s chief executive officer, may be deemed a beneficial owner and disclaims beneficial ownership.

Beneficially owned shares 352,472 shares Common Stock issuable upon exercise of warrants; as of September 30, 2026.
Percent of class 5.64% Reported beneficial ownership as of September 30, 2026.
Shares outstanding 6,244,558 shares Count based on the Form 10-Q dated August 6, 2026.
beneficially owned financial
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power of 352,472 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power of 352,472 shares"
warrants financial
"shares of Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALGS shares do the reporting persons beneficially own?

The reporting persons report 352,472 shares of Common Stock, or 5.64% of the class, as of September 30, 2026. The shares are issuable upon exercise of warrants.

Who holds the shares in the ALGS ownership report?

Alyeska Master Fund, L.P. holds the position, and Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control. Anand Parekh may be deemed a beneficial owner and disclaims beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





01626L204

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alyeska Investment Group, L.P.
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:11/16/2026
Alyeska Fund GP, LLC
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:11/16/2026
Anand Parekh
Signature:Anand Parekh
Name/Title:Anand Parekh | Self
Date:11/16/2026
Exhibit Information

As of September 30, 2026, the Reporting Persons beneficially own 352,472 shares of Common Stock issuable upon exercise of warrants. The number of shares of Common Stock outstanding (6,244,558) is based on the Form 10-Q dated August 6, 2026. Position held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control over the shares held by Alyeska Master Fund, L.P. Anand Parekh, as Chief Executive Officer of Alyeska Investment Group, L.P., may be deemed the beneficial owner of such shares. Mr. Parekh disclaims beneficial ownership of such shares. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Keep reading